Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Valneva Se ADR (VALN)

Valneva Se ADR (VALN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 527,160
  • Shares Outstanding, K 69,638
  • Annual Sales, $ 166,360 K
  • Annual Income, $ -109,780 K
  • 60-Month Beta 2.22
  • Price/Sales 3.13
  • Price/Cash Flow N/A
  • Price/Book 3.85
Trade VALN with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate 0.77
  • Number of Estimates 2
  • High Estimate 1.08
  • Low Estimate 0.45
  • Prior Year -0.28
  • Growth Rate Est. (year over year) +375.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.24 +4.28%
on 04/30/24
8.89 -15.07%
on 04/11/24
-0.17 (-2.20%)
since 04/02/24
3-Month
6.58 +14.74%
on 03/06/24
8.89 -15.07%
on 04/11/24
-0.54 (-6.67%)
since 02/02/24
52-Week
6.58 +14.74%
on 03/06/24
17.05 -55.72%
on 06/20/23
-2.16 (-22.25%)
since 05/02/23

Most Recent Stories

More News
Pharma Giant Pfizer Looks Strong for Investors, Despite COVID Sales Drop

The company is doubling down on its vaccine success.

PFE : 27.75 (+2.10%)
BNTX : 91.96 (+2.23%)
VALN : 7.55 (-0.26%)
Valneva (VALN) Stock Down 61.5% in the Past Year: Here's Why

Valneva's (VALN) COVID-19 vaccine looks promising, but the European Commission's revised advance purchase agreement jeopardizes its COVID-19 vaccine program.

AZN : 76.03 (-0.50%)
PFE : 27.75 (+2.10%)
ALLO : 2.95 (+1.03%)
VALN : 7.55 (-0.26%)
What Makes Valneva SE Sponsored ADR (VALN) a New Buy Stock

Valneva SE Sponsored ADR (VALN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

VALN : 7.55 (-0.26%)
Valneva (VALN) Up on Antibody Persistence Data on Chikungunya Jab

Valneva (VALN) posts encouraging 12-month antibody persistence data for its single-shot chikungunya vaccine candidate, VLA1553. Shares rise.

PFE : 27.75 (+2.10%)
AGLE : 12.01 (+8.79%)
ASLN : 0.4520 (-1.12%)
VALN : 7.55 (-0.26%)
Valneva (VALN) Up on 6-Month Lyme Disease Jab Persistence Data

Persistence data from a mid-stage study showed that Valneva's (VALN) Lyme disease vaccine elicited antibody levels which remained above baseline six months after completing dose administration in children...

PFE : 27.75 (+2.10%)
KMDA : 5.41 (+0.74%)
RPTX : 3.52 (+6.67%)
VALN : 7.55 (-0.26%)
Wall Street Analysts See a 65% Upside in Valneva SE Sponsored ADR (VALN): Can the Stock Really Move This High?

The mean of analysts' price targets for Valneva SE Sponsored ADR (VALN) points to a 65.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement...

VALN : 7.55 (-0.26%)
All You Need to Know About Valneva SE Sponsored ADR (VALN) Rating Upgrade to Buy

Valneva SE Sponsored ADR (VALN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

VALN : 7.55 (-0.26%)
Valneva (VALN) Stock Down 66% in the Past 6 Months: Here's Why

Valneva's (VALN) COVID-19 vaccine looks promising, but the European Commission's revised advance purchase agreement jeopardizes its COVID-19 vaccine program.

AZN : 76.03 (-0.50%)
PFE : 27.75 (+2.10%)
MORF : 28.62 (+2.32%)
VALN : 7.55 (-0.26%)
Valneva and VBI Vaccines Announce European Partnership for Marketing and Distribution of PreHevbri®

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) (Valneva) and VBI Vaccines Inc. (Nasdaq: VBIV) (VBI) today announced a partnership in select European markets for the marketing and distribution of PreHevbri®...

VALN : 7.55 (-0.26%)
VBIV : 0.5625 (-1.23%)
Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15

Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced the initiation of a Phase 3 clinical study, Vaccine Against Lyme for Outdoor Recreationists (VALOR) (NCT05477524),...

VALN : 7.55 (-0.26%)
PFE : 27.75 (+2.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Valneva SE is a specialty vaccine company. It is focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. Valneva SE is based in Saint-Herblain, France.

See More

Key Turning Points

3rd Resistance Point 8.02
2nd Resistance Point 7.90
1st Resistance Point 7.73
Last Price 7.55
1st Support Level 7.44
2nd Support Level 7.32
3rd Support Level 7.15

See More

52-Week High 17.05
Fibonacci 61.8% 13.05
Fibonacci 50% 11.81
Fibonacci 38.2% 10.58
Last Price 7.55
52-Week Low 6.58

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar